Skip to main content
SpringerLink
Log in
Book cover

Edible Medicinal and Non-Medicinal Plants pp 147–196Cite as

Piper methysticum

  • Chapter
  • First Online:

  • 1310 Accesses

Abstract

Cordate leaves of young kava seedling

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Selected References

  • Abourashed EA, Khan IA (2000) Microbial transformation of kawain and methysticin. Chem Pharm Bull 48(12):1996–1998

    Article  CAS  PubMed  Google Scholar 

  • Abu N, Ho WY, Yeap SK, Akhtar MN, Abdullah MP, Omar AR, Alitheen NB (2013) The flavokawains: uprising medicinal chalcones. Cancer Cell Int 13(1):102

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Abu N, Akhtar MN, Yeap SK, Lim KL, Ho WY, Zulfadli AJ, Omar AR, Sulaiman MR, Abdullah MP, Alitheen NB (2014) Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro. PLoS One 9(10):e105244

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Achenbach H, Karl W (1970) Uber die isolierung von zwei neuen pyrrolidinen aus rauschpfeffer. Chem Ber 103:2535–2540. (In German)

    Article  CAS  Google Scholar 

  • Achenbach H, Karl W (1971) Untersuchung der sauren des rauschpfeffers (Piper methysticum Forst.). Chem Ber 103:2535–2540

    Google Scholar 

  • Achenbach H, Wittman G (1970) Dihydrokawain-5-ol, ein neuer alkohol aus rauschpfeffer (Piper methysticum Forst.). Tetrahedron Lett 11(37):3259–3262

    Google Scholar 

  • Achenbach H, Karl W, Smith S (1971) Zur gaschromatograpischen trennung der kawa-lactone-(+)-5,6,7,8-tetrahydro-yangonin, ein neus kawa-lacton aus rauschpfeffers. Chem Ber 104:2688–2693

    Article  CAS  Google Scholar 

  • Achenbach H, Karl W, Regel W (1972) 11-Hydroxy-12-methoxy-dihydrokawain und 11,12-dimethoxy-dihydrokawain, zwei neue kawa-lactone aus rauschpfeffer (Piper methysticum Forst). Chem Ber 105:2182–2187

    Google Scholar 

  • Aitken RT (1930) Ethnology of Tubaui. Bernice P Bishop Mus Bull 70:42

    Google Scholar 

  • Almeida JC, Grimsley EW (1996) Coma from the health food store: interaction between kava and alprazolam. Ann Int Med 125(11):940–941

    Article  CAS  PubMed  Google Scholar 

  • Anke J, Ramzan I (2004) Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). J Ethnopharmacol 93(2–3):153–160

    Article  CAS  PubMed  Google Scholar 

  • Aufenanger H, Hötker G (1940) Die Gende in Zentralneuguinea, vom leben und denken eines Papua-Stammes im Bismarck gebirge. [The gende of central New Guinea, life and thought of a Papuan branch in the Bismarck mountains.] Erganzungsbande zur Ethnographie Neuguineas 1. Missionsdruckerei St. Gabriel, Wien-Modling. 209 pp

    Google Scholar 

  • Backhauss C, Krieglstein J (1992) Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 215(2–3):265–269

    Article  CAS  PubMed  Google Scholar 

  • Barrau J (1957) A propos du Piper methysticum Forster. J Agric Trop Bot Appl 4:270–273. (In French)

    Google Scholar 

  • Baum SS, Hill R, Rommelspacher H (1998) Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. Prog Neuropsychopharmacol Biol Psychiatry 22(7):1105–1120

    Article  CAS  PubMed  Google Scholar 

  • Behl M, Nyska A, Chhabra RS, Travlos GS, Fomby LM, Sparrow BR, Hejtmancik MR, Chan PC (2011) Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. Food Chem Toxicol 49(11):2820–2829

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bhate H, Gerster G, Gracza E (1989) Orale prämedikation mit zubereitungen aus Piper methysticum bei operativen eingriffen in epiduralanästhesie. Erfahrungsheilkunde 6:339–345. (In German)

    Google Scholar 

  • Bilia AR, Gallori S, Vincieri FF (2002) Kava-kava and anxiety: growing knowledge about the efficacy and safety. Life Sci 70(22):2581–2597

    Article  CAS  PubMed  Google Scholar 

  • Bobeldijk I, Boonzaaijer G, Spies-Faber EJ, Vaes WH (2005) Determination of kava lactones in food supplements by liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry. J Chromatogr A 1067(1–2):107–114

    Article  CAS  PubMed  Google Scholar 

  • Bodkin R, Schneider S, Rekkerth D, Spillane L, Kamali M (2012) Rhabdomyolysis associated with kava ingestion. Am J Emerg Med 30(4):635.e1-3

    Article  PubMed  Google Scholar 

  • Boonen G, Beck MA, Häberlein H (1997) Contribution to the quantitative and enantioselective determination of kavapyrones by high-performance liquid chromatography on ChiraSpher NT material. J Chromatogr B Biomed Sci Appl 702(1):240–244

    Article  CAS  PubMed  Google Scholar 

  • Boonen G, Ferger B, Kuschinsky K, Häberlein H (1998) In vivo effects of the kavapyrones (+)-dihydromethysticin and (+/−)-kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions. Planta Med 64(6):507–510

    Article  CAS  PubMed  Google Scholar 

  • Borsch W, Blount BK (1930) Untersuchungen über die bestandteile der kawawurzel. XI. Synthese der methystizinsaure und der kawasäure. Chem Ber 63:2418–2420. (In German)

    Article  Google Scholar 

  • Borsch W, Blount BK (1932) Untersuchungen über die bestandteile der kawawurzel. XII. Über yangonlakton und triacetäure. Chem Ber 65:820–828. (In German)

    Article  Google Scholar 

  • Borsch W, Blount BK (1933) Untersuchungen über die bestandteile der kawawurzel. XIII. Über einige neue stoffe aus technischen kawaharz. Chem Ber 66:803–806. (In German)

    Article  Google Scholar 

  • Borsch W, Lewinsohn M (1933) Untersuchungen über die bestandteile der kawawurzel. XIV. Über cinnamol-essigester. Chem Ber 66:1792–1801. (In German)

    Article  Google Scholar 

  • Borsche W (1927) Untersuchungen über die bestandteile der kawawurzel. III. Über die katalytische hydrierung des methystizins. Chem Ber 60:982–984. (In German)

    Article  Google Scholar 

  • Borsche W, Bodenstein CK (1929) Untersuchungen uber die bestandteile der kawawurzel. IX. Die syntheses des yangonins. Chem Ber 62:2515–2523. (In German)

    Article  Google Scholar 

  • Borsche W, Gerhard M (1914) Untersuchungen über die bestandteile der kawawurzel.I. Über yangonin. Chem Ber 47:2902–2918. (In German)

    Article  CAS  Google Scholar 

  • Borsche W, Peitzsch W (1929a) Untersuchungen über die bestandteile der kawawurzel. VII. Über kawasäure. Chem Ber 62:368–373. (In German)

    Article  Google Scholar 

  • Borsche W, Peitzsch W (1929b) Untersuchungen über die bestandteile der kawawurzel. VII. Über pseudo-methystizin. Chem Ber 62:360–367. (In German)

    Article  Google Scholar 

  • Borsche W, Peitzsch W (1930) Untersuchungen über die bestandteile der kawawurzel. X. Über kawain and dihydrokawain. Chem Ber 63:2414–2417. (In German)

    Article  Google Scholar 

  • Borsche W, Roth A (1921) Untersuchungen über die bestandteile der kawawurzel.II. Über das kawaharz. Chem Ber 54:2229–2235. (In German)

    Article  Google Scholar 

  • Borsche W, Walter C (1927) Untersuchungen über die bestandteile der kawawurzel. V. Syntheses des yangonols. Chem Ber 60:2112. (In German)

    Article  Google Scholar 

  • Borsche W, Meyer CH, Peitzsch W (1927a) Untersuchungen über die bestandteile der kawawurzel. VI. Die constitution des methystizins. Chem Ber 60:2113–2120. (In German)

    Article  Google Scholar 

  • Borsche W, Rosenthal W, Meyer CH (1927b) Untersuchungen über die bestandteile der kawawurzel. IV. Über die synthese eines kawasaure-methyesters und zweier isomer des methystizins. Chem Ber 60:1135–1139. (In German)

    Article  Google Scholar 

  • Brown AC, Onopa J, Holck P, Kaufusi P, Kabasawa D, Craig WJ, Dragull K, Levine AM, Baker JD (2007) Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clin Toxicol (Phila) 45(5):549–556

    Article  CAS  Google Scholar 

  • Brüggemann F, Meyer HJ (1962) Die analgetische wirkung der kawa-inhaltsstoffe dihydrokawain und dihydromethysticin. Arzneim Forsch 12:407–409. (In German)

    Google Scholar 

  • Bruner NR, Anderson KG (2009) Discriminative-stimulus and time-course effects of kava-kava (Piper methysticum) in rats. Pharmacol Biochem Behav 92(2):297–303

    Article  CAS  PubMed  Google Scholar 

  • Buckley JP, Furgiuele AR, O’Hara MJ (1967) Pharmacology of kava. In: Efron DH (ed) Ethnopharmacologic search for psychoactive drugs, United States Public Health Service publication no. 1645. United States Public Health Service, Washington, DC

    Google Scholar 

  • Cagnacci A, Arangino S, REnzi A, Zanni AL, Malmusi S, Volpe A (2003) Kava- kava administration reduces anxiety in perimenopausal women. Maturitas 44(2):103–109

    Article  PubMed  Google Scholar 

  • Cairney S, Maruff P, Clough AR (2002) The neurobehavioural effects of kava. Aust N Z J Psychiatry 36(5):657–662

    Article  PubMed  Google Scholar 

  • Cairney S, Maruff P, Clough AR, Collie A, Currie J, Currie BJ (2003) Saccade and cognitive impairment associated with kava intoxication. Hum Psychopharmacol 18(7):525–533

    Article  PubMed  Google Scholar 

  • Campo JV, McNabb J, Perel JM, Mazariegos GV, Hasegawa SL, Reyes J (2002) Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry 41(6):631–632

    Article  PubMed  Google Scholar 

  • Cawte J (1986) Parameters of kava used as a challenge to alcohol. Aust NZ J Psychiatry 20(1):70–76

    Article  CAS  Google Scholar 

  • Cawte J (1988) Macabre effects of a cult for kava. Med J Aust 148(11):545–546

    CAS  PubMed  Google Scholar 

  • Cheng D, Lidgard RO, Duffield PH, Duffield AM (1988) Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed Environ Mass Spectrom 17(5):371–376

    Article  CAS  PubMed  Google Scholar 

  • Chienthavorn O, Smith RM, Wilson ID, Wright B, Lenz EM (2005) Superheated water chromatography-nuclear magnetic resonance spectroscopy of kava lactones. Phytochem Anal 16(3):217–221

    Article  CAS  PubMed  Google Scholar 

  • Clouatre DL (2004) Kava kava: examining new reports of toxicity. Toxicol Lett 150(1):85–96

    Article  CAS  PubMed  Google Scholar 

  • Clough AR (2003) Enough! or too much. What is ‘excessive’ kava use in Arnhem Land? Drug Alcohol Rev 22(1):43–51

    Article  PubMed  Google Scholar 

  • Clough AR, Bailie RS, Currie B (2003a) Liver function test abnormalities in users of aqueous kava extracts. J Toxicol Clin Toxicol 41(6):821–829

    Article  PubMed  Google Scholar 

  • Clough AR, Jacups SP, Wang Z, Burns CB, Bailie RS, Cairnery SJ, Collie A, Guyula T, McDoanld SP, Currie BJ (2003b) Health effects of kava use in an eastern Arnhem Land aboriginal community. Intern Med J 33(8):336–340

    Article  CAS  PubMed  Google Scholar 

  • Côté CS, Kor C, Cohen J, Auclair K (2004) Composition and biological activity of traditional and commercial kava extracts. Biochem Biophys Res Commun 322(1):147–152

    Article  PubMed  CAS  Google Scholar 

  • Cuzent G (1981) Rapport sur la composition chimique de la kavahine. CR Acad Sci Paris 52(5):205–206. (In French)

    Google Scholar 

  • Davies LP, Drew CA, Duffield P, Johnston GA, Jamieson DD (1992) Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71(2):120–126

    Article  CAS  PubMed  Google Scholar 

  • de Jager LS, Perfetti GA, Diachenko GW (2004) LC-UV and LC-MS analysis of food and drink products containing kava. Food Addit Contam 21(10):921–934

    Article  PubMed  CAS  Google Scholar 

  • De Leo V, La Marca A, Lanzetta D, Palazzi S, Torricelli M, Facchini C, Morgante G (2000) Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety. Minerva Ginecol 52(6):263–267. (In Italian)

    PubMed  Google Scholar 

  • Degener O (1945) Plants of Hawaii National Park, 2nd edn. Edwards Brothers, Waialua, Oahu, Hawaii

    Google Scholar 

  • Degener O (1949) Naturalists’ South Pacific expedition: Fiji. Paradise of the Pacific, Ltd, Honolulu. 303 pp

    Google Scholar 

  • Denham A, McIntyre M, Whitehouse J (2002) Kava – the unfolding story: report on a work-in-progress. J Altern Complement Med 8(3):237–263

    Article  PubMed  Google Scholar 

  • Dentali SJ (1997) Herb Safety Review, Piper methysticum Forster f. (Piperaccae). Herb Research Foundation, Boulder

    Google Scholar 

  • Dharmaratne HRW, Nanayakkara NPD, Khan IA (2002) Kavalactones from Piper methysticum and their 13C NMR spectroscopic analyses. Phytochemistry 59:429–433

    Article  CAS  PubMed  Google Scholar 

  • Dinh LD, Simmen U, Bueter KB, Bueter B, Lundstrom K, Schaffner W (2001) Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Planta Med 67(4):306–311

    Google Scholar 

  • DiSilvestro RA, Zhang W, DiSilvestro DJ (2007) Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem Toxicol 45(7):1293–1300

    Article  CAS  PubMed  Google Scholar 

  • Dragull K, Yoshida WY, Tang CS (2003) Piperidine alkaloids from Piper methysticum. Phytochemistry 63(2):193–198

    Article  CAS  PubMed  Google Scholar 

  • Duffield PH, Jamieson DD (1991) Development of tolerance to kava in mice. Clin Exp Pharmacol Physiol 18(8):571–578

    Article  CAS  PubMed  Google Scholar 

  • Duffield AM, Lidgard RO (1986) Analysis of kava resin by gas chromatography and electron impact and methane negative ion chemical ionization mass spectrometry. New trace constituents of kava resin. Biol Mass Spectrom 13:621–626

    Article  CAS  Google Scholar 

  • Duffield AM, Lidgard RO, Low GKC (1986) Analysis of the constituents of Piper methysticum by gas chromatography methane chemical ionization mass spectrometry. New constituents of kava resin. Biol Mass Spectrom 13:305–313

    Article  CAS  Google Scholar 

  • Duffield AM, Jamieson DD, Lidgard RO, Duffield PH, Bourne DJ (1989a) Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr A 475(2):273–281

    Article  CAS  Google Scholar 

  • Duffield PH, Jamieson DD, Duffield AM (1989b) Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats. Arch Int Pharmacodyn Ther 301:81–90

    CAS  PubMed  Google Scholar 

  • Dutta CP, Ray LPK (1973) Further studies on the structure of flavokawain C. A new chalcone isolated from Piper methysticum. Indian Sci Congress Assoc Proc 60:121–122

    Google Scholar 

  • Dutta CP, Ray LPK, Chatterjee A, Roy DN (1972) Constituents of Piper methysticum. Phytochemistry 11(9):2891–2892

    Article  CAS  Google Scholar 

  • Dutta CP, Ray LPK, Chatterjee A, Roy DN (1973) Constituents of flavokawain C. Piper methysticum. Ind J Chem 11(5):509–510

    CAS  Google Scholar 

  • Dutta CP, Ray LPK, Chatterjee A, Roy DN (1976) Studies on the genus Piper. V. Chemical investigation of Piper methysticum Forst. (Piperqceae). Structure and synthesis of flavokawain C. J Ind Chem Soc 53(12):1194–1197

    CAS  Google Scholar 

  • Dutta CP, Som UK (1978) Studies on the genus Piper – VIII. Further studies on the roots of Piper methysticum Forst. J Indian Chem Soc 55:932–934

    Google Scholar 

  • Duve RN (1976) Highlight of the chemistry and pharmacology of yaqona, Piper methysticum. Fiji Agric J 38(2):81–84

    CAS  Google Scholar 

  • Duve RN (1981) Gas-liquid chromatographic determination of major constituents of Piper methysticum. Analyst 106:160–165

    Article  CAS  Google Scholar 

  • Duve RN, Prasad J (1983) Changes in the chemical composition of yaqona Piper methysticum with time. Fiji Agric J 45(2):45–50

    CAS  Google Scholar 

  • Emser W, Bartylla K (1991) Verbesserung der schlafqualität. Zur wirkung von kava-extrakt WS 1490 auf das schlafmuster bei gesunden. TW Neurol Psychiatr 5:636–642. (In German)

    Google Scholar 

  • Ernst E, Pittler MH, Stevinson C, White AR, Eisenberg D (2001) The desktop guide to complementary and alternative medicine. Mosby, Edinburgh

    Google Scholar 

  • Eskander RN, Randall LM, Sakai T, Guo Y, Hoang B, Zi X (2012) Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. J Obstet Gynaecol Res 38(8):1086–1094

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Fackelmann KA (1992) The history, chemistry and botany of the mind-altering kava plant. Sci News 141:424–425

    Article  Google Scholar 

  • Feltenstein MW, Lambdin LC, Ganzera M, Ranjith H, Dharmaratne W, Nanayakkara NP, Khan IA, Sufka KJ (2003) Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother Res 17(3):210–216

    Article  PubMed  Google Scholar 

  • Folmer F, Blasius R, Morceau F, Tabudravu J, Dicato M, Jaspars M, Diederich M (2006) Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol 71(8):1206–1218

    Article  CAS  PubMed  Google Scholar 

  • Frater AS (1958) Medical aspects of kava. Trans Proc Fiji Soc 5(2):31–39

    Google Scholar 

  • Fu S, Rowe A, Ramzan I (2012) Kavalactone metabolism in the isolated perfused rat liver. Phytother Res 26(12):1813–1816

    Article  CAS  PubMed  Google Scholar 

  • Furgiuele AR, Kinnard WJ, Aceto MD, Buckley JP (1965) Central activity of aqueous extracts of Piper methysticum (kava). J Pharm Sci 54(2):247–252

    Article  CAS  PubMed  Google Scholar 

  • Garner LF, Klinger JD (1985) Some visual effects caused by the beverage kava. J Ethnopharmacol 13(3):307–311

    Article  CAS  PubMed  Google Scholar 

  • Garrett KM, Basmadjian G, Khan IA, Schaneberg BT, Seale TW (2003) Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice. Psychopharmacology (Berl) 170(1):33–41

    Article  CAS  Google Scholar 

  • Gastpar M, Klimm HD (2003) Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial. Phytomedicine 10(8):631–639

    Article  CAS  PubMed  Google Scholar 

  • Gautz LD, Kaufusi P, Jackson MC, Bittenbender HC, Tang CS (2006) Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression. J Agric Food Chem 54(17):6147–6152

    Article  CAS  PubMed  Google Scholar 

  • Gessner B, Cnota P (1994) Untersuchung der vigilanz nach applikation von kava-kava-extrakt, diazepam oder placebo. (Extract of the kava-kava rhizome in comparison with diazepam and placebo). Z Phytother 15:30–37. (In German)

    Google Scholar 

  • Gleitz J, Beile A, Peters T (1995) (+/−)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex. Neuropharmacology 34(9):1133–1138

    Article  CAS  PubMed  Google Scholar 

  • Gleitz J, Beile A, Peters T (1996a) (+/−)-kavain inhibits the veratridine- and KCl-induced increase in intracellular Ca2+ and glutamate-release of rat cerebrocortical synaptosomes. Neuropharmacology 35(2):179–186

    Article  CAS  PubMed  Google Scholar 

  • Gleitz J, Friese J, Beile A, Ameri A, Peters T (1996b) Anticonvulsive action of (+/−)-kavain estimated from its properties on stimulated synaptosomes and Na + channel receptor sites. Eur J Pharmacol 315(1):89–97

    Google Scholar 

  • Gleitz J, Beile A, Wilkins P, Ameri A, Peters T (1997) Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med 63(1):27–30

    Article  CAS  PubMed  Google Scholar 

  • Gounder R (2006) Kava consumption and its health effects. Pacific Health Dialog 13(2):131–135

    PubMed  Google Scholar 

  • Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW (2003) Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 178(9):442–443

    PubMed  Google Scholar 

  • Grace RF (2003) Kava drinking in Vanuatu – a hospital based survey. Pacific Health Dialog 10(2):41–44

    PubMed  Google Scholar 

  • Gracza L, Ruff P (1986) Uber die hoheren alkohole von Piperis methystici rhizome: aliphatic and alicyclic alcohols of Piperis methystici rhizome. Arch Pharm 319:475–477

    Article  CAS  Google Scholar 

  • Grunze H, Langosch J, Schirrmacher K, Bingmann D, Von Wegerer J, Walden J (2001) Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers – a review. Prog Neuropsychopharmacol Biol Psychiatry 25(8):1555–1570

    Article  CAS  PubMed  Google Scholar 

  • Guérin J-C, Réveillère HP (1984) Activité antifongique d’extraits végétaux à usage thérapeutique. I. Étude de 41 extraits sur 9 souches fongiques. Ann Pharm Fr 42:553–559. (In French)

    PubMed  Google Scholar 

  • Guo L, Li Q, Xia Q, Dial S, Chan PC, Fu P (2009) Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food Chem Toxicol 47(2):433–442

    Article  CAS  PubMed  Google Scholar 

  • Guo L, Shi Q, Dial S, Xia QS, Mei N, Li QZ, Chan PC, Fu P (2010) Gene expression profiling in male B6C3F1 mouse livers exposed to kava identifies – changes in drug metabolizing genes and potential mechanisms linked to kava toxicity. Food Chem Toxicol 48(2):686–696

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Häberlein H, Boonen G, Beck MA (1997) Piper methysticum: enantiomeric separation of kavapyrones by high performance liquid chromatography. Planta Med 63(1):63–65

    Article  PubMed  Google Scholar 

  • Halzl JS, Juretzek W, StahlBiskup E (1993) Piper. In: von Bruchhausen F, et al (12 others) (eds) Hagers Handbuch der Pharmazeutischen Praxis, 5th edn. Springer, Berlin. 5:52–59

    Google Scholar 

  • Handy ESC (1940) The Hawaian planter. Volume I. His plants, methods and areas of cultivation, Bernice P. Bishop Mus Bull 161. 227pp

    Google Scholar 

  • Handy ESC, Pukui MK, Livermore K (1934) Outline of Hawaiian physical therapeutics, Bernice P. Bishop Museum Bull 126. 51 pp

    Google Scholar 

  • Hannam S, Murray M, Romani L, Tuicakau M, Whitfeld MJ (2014) Kava dermopathy in Fiji: an acquired ichthyosis? Int J Dermatol 53(12):1490–1494

    Article  PubMed  Google Scholar 

  • Hänsel R (1968) Characterisation and physiological activity of some kava constituents. Pacific Sci 22:293–313

    Google Scholar 

  • Hänsel R, Klaproth L (1966) Isolierung von 11-methoxy-yangonin aus der kawawurzel. Arch Pharm 299:503–506

    Article  Google Scholar 

  • Hänsel R, Schulz J (1973) Synthese von racem 5,6-cis- und trans-kawain-5-ol. Chem Ber 106:570–575

    Article  PubMed  Google Scholar 

  • Hänsel R, Baehr P, Elich J (1961) Isolierung und charakterisierung von zwei bisher unbekannten farbstoffen des kawa-rhizoms eine vorläufige mitteilung. Arch Pharm 294:739–743. (In German)

    Article  Google Scholar 

  • Hänsel R, Ranft G, Baehr P (1963) Zwei chalkonpigmente aus Piper methysticum Forst. 4. Mitt.: Zur frage der biosynthese der kawalaktone. Naturfosch B18(5):370–373. (In German)

    Google Scholar 

  • Hänsel R, Wiess D, Schmidt B (1966a) Fungistatische wirkung der kawadroge und ihrer inhaltsstoffe. Planta Med 14(1):1–9. (In German)

    Article  Google Scholar 

  • Hänsel R, Rimpler H, Langhammer L (1966b) IR-Spektren der α-pyrone vom yangonin-und kawain-type und synthese von 4-methoxy-5,6-dihydro-6-methyl-pyron-2 alsmodellsubstanz. Z Anal Chem 218:346–353

    Article  Google Scholar 

  • Hänsel R, Sauer H, Rimpler H (1966c) 11-Methoxy-nor-yangonin aus einer botanisch nicht beschriebenen Piperart Neu-Guineas. Arch Pharm 299:507–512

    Article  Google Scholar 

  • Hänsel R, Weiss D, Schmidt B (1968) Kawalaktone: Kettenlange und fungistatische Wirkung. Archr Pharm 301:369–373. (In German)

    Article  Google Scholar 

  • Hapke HJ, Sterner W, Heisler E, Brauer H (1971) Toxicological studies with Kavaform. Farmaco Ed Prat 26(11):692–720

    CAS  Google Scholar 

  • Harrington MT, Scotese P (eds) (2001) Samoan medicinal plants and their usage. ADAP (Amercian Devleopment in the American Pacific) project, 2nd edn. Reprint. Pacific Agricultural Development Office, Tropical Energy House, University of Hawaii. 162 pp

    Google Scholar 

  • Hashimoto T, Suganuma M, Fujiki H, Yamada M, Kohno T, Asakawa X (2003) Isolation and synthesis of TNF-a release inhibitors from Fijian kawa (Piper methysticum). Phytomedicine 10(4):309–317

    Article  CAS  PubMed  Google Scholar 

  • He XG, Lin LZ, Lian LZ (1997) Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava. Planta Med 63(1):70–74

    Article  CAS  PubMed  Google Scholar 

  • Heinze HJ, Munte TF, Steitz J, Matzke M (1994) Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials. Pharmacopsychiatry 27(6):224–230

    Article  CAS  PubMed  Google Scholar 

  • Herberg KW (1991) Fahrtüchtigkeit nach einnahme von kava-spezialextrakt WS 1490. Z Allg Med 67:842–846

    Google Scholar 

  • Herberg KW (1993) Zum einfluss von kava-spezialextrakt WS 1490 in kombination mit ethylalkohol auf sicherheitsrelevante leistungsparameter. Blutalkohol 30:96–105

    CAS  PubMed  Google Scholar 

  • Herberg KW (1996) Alltagssicherheit unter kava-kava-extrakt, bromazepam und deren Kombination. Z Allg Med 72:973–977

    Google Scholar 

  • Hirsch M (2000) What are the uses and dangers of kava? Harv Ment Health Lett 17:8

    CAS  PubMed  Google Scholar 

  • Holdsworth DK (1977) Medicinal plants of Papua New Guinea. South Pacific Commission, Noumea, techn paper 175. 123p

    Google Scholar 

  • Holm E, Staedt U, Heep J, Koetsik C, Behne F, Kaske S, Mennicke I (1991) Untersuchungen zum wirkungsprofil von d,l-kavain. Zerebrale angriffsorte und schlaf-wach-rhythmus im tierexperiment.(The action profile of d,l-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals) Arzneim Forsch 41:673–683. (In German)

    Google Scholar 

  • Hsu SY, Lin MH, Lin LC, Chou CJ (1994) Toxicologic studies of dihydro-5,6-dehydrokawain and 5,6-dehydrokawain. Planta Med 60(1):88–90

    Article  CAS  PubMed  Google Scholar 

  • Humberston CL, Akhtar J, Krenzelok EP (2003) Acute hepatitis induced by kava kava. Clin Toxicol 41(2):109–113

    CAS  Google Scholar 

  • Huynh JC, Asgari MM, Moore MM (2014) Sebotropic eruption associated with use of oral kava kava supplement. Clin Exp Dermatol 39(7):816–818

    Article  CAS  PubMed  Google Scholar 

  • Jaggy H, Achenbach H (1992) Cepharadione A from Piper methysticum. Planta Med 58:111

    Article  CAS  PubMed  Google Scholar 

  • Jamieson DD, Duffield PH (1990a) Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol 17(7):509–514

    Article  CAS  PubMed  Google Scholar 

  • Jamieson DD, Duffield PH (1990b) The antinociceptive actions of kava components in mice. Clin Exp Pharmacol Physiol 17(7):495–507

    Article  CAS  PubMed  Google Scholar 

  • Jamieson DD, Duffield PH, Cheng D, Duffield AM (1989) Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn Ther 301:66–80

    CAS  PubMed  Google Scholar 

  • Jappe U, Franke I, Reinhold D, Gollnick HP (1998) Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity? J Am Acad Dermatol 38(1):104–106

    Article  CAS  PubMed  Google Scholar 

  • Jarrett LH (1933) Hawaii and its people. Honolulu Star-Bull, Honolulu. 319 pp

    Google Scholar 

  • Jeurissen SM, Claassen FW, Havlik J, Bouwmans EE, Cnubben NH, Sudholter EJ, Rietjens IM, van Beek TA (2007) Development of an on-line high performance liquid chromatography detection system for human cytochrome P450 1A2 inhibitors in extracts of natural products. J Chromatogr A 1141(1):81–89

    Article  CAS  PubMed  Google Scholar 

  • Jhoo JW, Freeman JP, Heinze TM, Moody JD, Schnackenberg LK, Beger RD, Dragull K, Tang CS, Ang CY (2006) In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 54(8):3157–3162

    Article  CAS  PubMed  Google Scholar 

  • Jhoo JW, Ang CY, Heinze TM, Deck J, Schnackenberg LK, Beger RD, Dragull K, Tang CS (2007) Identification of C-glycoside flavonoids as potential mutagenic compounds in kava. J Food Sci 72(2):C120–C125

    Article  CAS  PubMed  Google Scholar 

  • Ji T, Lin C, Krill LS, Eskander R, Guo Y, Zi XL, Hoang BH (2013) Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis. Mol Cancer 12:55

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Johnson D, Frauendorf A, Stecker K, Stein U (1991) Neurophysiologisches Wirkprofil und verträglichkeit von kava-extrakt WS 1490. Eine pilotstudie mit randomisierter auswertung. Neurol Psychiatr 5:349–354. (Neurophysiological active profile and tolerance of kava extract WS 1490, a pilot study with randomized evaluation) (In German)

    Google Scholar 

  • Johnson TE, Kassie F, O’Sullivan MG, Negia M, Hanson TE, Upadhyaya P, Ruvolo PP, Hecht SS, Xing C (2008) Chemopreventive effect of kava on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumorigenesis in A/J mice. Cancer Prev Res (Phila Pa) 1(6):430–438

    Article  CAS  Google Scholar 

  • Johnson TE, Hermanson D, Wang L, Kassie F, Upadhyaya P, O’Sullivan MG, Hecht SS, Lu J, Xing C (2011) Lung tumorigenesis suppressing effects of a commercial kava extract and its selected compounds in A/J mice. Am J Chin Med 39(4):727–742

    Article  CAS  PubMed  Google Scholar 

  • Jössang P, Holho D (1967) Chromatographie sur couches épaisses non liées des constituants du rhizome de Piper methysticum: Isolement de deux nouvelles cétones, cinnamalacétone et methylénedioxy-3,4-cinnamalacétone. J Chromatogr 31:375–383 (In French)

    Article  Google Scholar 

  • Jössang P, Molho D (1970) Etude des constituants des feuilles de Piper methysticum Forst. Bull Mus Nat Hist Nat 3rd Ser 42:440–447. (In French)

    Google Scholar 

  • Jussofie A, Schmiz A, Hiemke C (1994) Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology (Berl) 116(4):469–474

    Article  CAS  Google Scholar 

  • Keledjian J, Duffield PH, Jamieson DD, Lidgard RO, Duffield AM (1988) Uptake into mouse brain of four compounds present in the psychoactive beverage kava. J Pharm Sci 77(12):1003–1006

    Article  CAS  PubMed  Google Scholar 

  • Keller F, Klohs M (1963) A review of the chemistry and pharmacology of the constituents of Piper methysticum. Lloydia 26:1–15

    Google Scholar 

  • Kinzler E, Kromer J, Lehmann E (1991) Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks. Arzneim Forsch 41(6):584–588

    CAS  Google Scholar 

  • Kleiser B, Diepers M, Wagner N, Ludolph AC (1998) Treatment of intracerebral hematomas with kava in rats. Neurology 50(4):a398

    Google Scholar 

  • Klohs MW (1967) Chemistry of kava. In: Efron D (ed) Ethnopharmacologic search for psychoactive drugs. Department of Health, Education, and Welfare, Washington DC, pp 126–132

    Google Scholar 

  • Klohs MW, Keller F, Williams RE, Toekes ML, Cronheim GE (1959) A chemical and pharmacological investigation of Piper methysticum Forst. J Med Pharm Chem 1(1):95–103

    Article  CAS  PubMed  Google Scholar 

  • Kormann EC, Amaral Pde A, David M, Eifler-Lima VL, Cechinel Filho V, Campos Buzzi F (2012) Kavain analogues as potential analgesic agents. Pharmacol Rep 64(6):1419–1426

    Article  CAS  PubMed  Google Scholar 

  • Kretzschmar R, Meyer HJ (1969) Comparative studies on the anticonvulsant activity of the pyrone compounds of Piper methysticum Forst. Arch Int Pharmacodyn 177:261–267. (In German)

    Google Scholar 

  • Kretzschmar R, Meyer HJ, Teschendorf HJ, Zöllner B (1969) Spasmolytische wirksamkeit von arylsubstituierten ot-pyronen und wässrigen extrakten aus Piper methysticum Forst. Arch Int Pharmacodyn Ther 180:475–491

    CAS  PubMed  Google Scholar 

  • Kretzschmar R, Meyer HJ, Teschendorf HJ (1970) Strychnine antagonistic potency of pyrone compounds of the kavaroot (Piper methysticum Forst.). Experientia 26(3):283–284

    Article  CAS  PubMed  Google Scholar 

  • Kretzschmar R, Teschendorf H, Ladous A, Ettehadieh D (1971) On the sedative action of the kava rhizome (Piper methysticum). Acta Pharmacol Toxicol 29(4):26

    Google Scholar 

  • Kubátová A, Miller DJ, Hawthorne SB (2001) Comparison of subcritical water and organic solvents for extracting kava lactones from kava root. J Chromatogr A 923(1–2):187–194

    Article  PubMed  Google Scholar 

  • Kwon DJ, Ju SM, Youn GS, Choi SY, Park J (2013) Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages. Food Chem Toxicol 58:479–486

    Article  CAS  PubMed  Google Scholar 

  • Langosch JM, Normann C, Schirrmacher K, Berger M, Walden J (1998) The influence of (+/−)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices. Comp Biochem Physiol A Mol Integr Physiol 120(3):545–549

    Article  CAS  PubMed  Google Scholar 

  • LaPorte E, Sarris J, Stough C, Scholey A (2011) Neurocognitive effects of kava (Piper methysticum): a systematic review. Hum Psychopharmacol 26(2):102–111

    Article  CAS  PubMed  Google Scholar 

  • Lebot V, Cabalion P (1988) Kavas of Vanuatu. Cultivars of Piper methysticum Forst, Technical paper no. 195. South Pacific Commission, Noumea. 191pp

    Google Scholar 

  • Lebot V, Lévesque J (1989) The origin and distribution of Kava (Piper methysticum Forst. f., Piperaceae): a phytochemical approach. Allertonia 5(2):2231–2281

    Google Scholar 

  • Lebot V, Lévesque J (1996) Evidence for conspecificity of Piper methysticum Forst. f. and Piper wichmannii C. DC. Biochem Syst Ecol 24:775–782

    CAS  Google Scholar 

  • Lebot V, Merling M, Lindstrom L (1992) Kava the Pacific elixir the definitive guide to its ethnobotany, history, and chemistry. Yale University Press, New Haven. 255pp

    Google Scholar 

  • Lebot V, Do TK, Legendre L (2014) Detection of flavokavins (A, B, C) in cultivars of kava (Piper methysticum) using high performance thin layer chromatography (HPTLC). Food Chem 151:554–560

    Article  CAS  PubMed  Google Scholar 

  • Lechtenberg M, Quandt B, Kohlenberg FJ, Nahrstedt A (1999) Qualitative and quantitative micellar electrokinetic chromatography of kavalactones from dry extracts of Piper methysticum Forst. and commercial drugs. J Chromatogr A 848(1):457–464

    Google Scholar 

  • Lechtenberg M, Quandt B, Schmidt M, Nahrstedt A (2008) Is the alkaloid pipermethystine connected with the claimed liver toxicity of Kava products? Pharmazie 63(1):71–74

    CAS  PubMed  Google Scholar 

  • Lehmann E, Kinzler E, Friedemann J (1996) Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin – a double-blind placebo-controlled study of four weeks treatment. Phytomedicine 3(2):113–119

    Article  CAS  PubMed  Google Scholar 

  • Leitzman P, Narayanapillai SC, Balbo S, Zhou B, Upadhyaya P, Shaik AA, O’Sullivan MG, Hecht SS, Lu J, Xing C (2014) Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice. Cancer Prev Res (Phila) 7(1):86–96

    Article  CAS  Google Scholar 

  • Leung AY, Foster S (1996) Encyclopedia of common natural ingredients. Wiley, New York

    Google Scholar 

  • Lewin L (1886) Über Piper methysticum (Kawa). Hirschwald, Berlin. 60 pp

    Google Scholar 

  • Li Y, Mei H, Wu QG, Zhang SH, Fang JL, Shi LM, Guo L (2011) Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1. Toxicol Sci 124(2):388–399

    Article  CAS  PubMed  Google Scholar 

  • Li XS, Liu ZB, Xu X, Blair CA, Sun Z, Xie J, Lilly MB, Zi XL (2012) Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice. PLoS One 7(2):e31213

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Li XS, Xu X, Ji T, Liu ZB, Gu M, Hoang BH, Zi XL (2014) Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Toxicol Rep 1:2–11

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Ligresti A, Villano R, Allarà M, Ujváry I, Di Marzo V (2012) Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB1 receptor ligand. Pharmacol Res 66(2):163–169

    Article  CAS  PubMed  Google Scholar 

  • Lim ST, Dragull K, Tang CS, Bittenbender HC, Efird JT, Nerurkar PV (2007) Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci 97(1):214–221

    Article  CAS  PubMed  Google Scholar 

  • Liu ZB, Xu X, Li XS, Liu SM, Simoneau AR, He F, Wu XR, Zi XL (2013) Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model. Cancer Prev Res (Phila) 6(12):1365–1375

    Article  CAS  Google Scholar 

  • Locher CP, Burch MT, Mower HF, Berestecky J, Davis H, Van Poel B, Lasure A, Vanden Berghe DA, Vlietinck AJ (1995) Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 49(1):23–32

    Article  CAS  PubMed  Google Scholar 

  • Lopez-Avila V, Benedicto J (1997) Supercritical fluid extraction of kava lactones from Piper methysticum (Kava) herb. J High Resol Chromatogr 20:555–559

    Article  CAS  Google Scholar 

  • Lopez-Avila V, Yefchak G (2009) Identification of compounds in commercial kava extracts by gas chromatography with electron ionization high-resolution mass spectrometry. Open Anal Chem J 3:22–31

    Article  CAS  Google Scholar 

  • Lüde S, Török M, Dieterle S, Jäggi R, Büter KB, Krähenbühl S (2008) Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 15(1–2):120–131

    Article  PubMed  CAS  Google Scholar 

  • Ma YZ, Sachdeva K, Liu JR, Ford M, Yang DF, Khan IA, Chichester CO, Yan BF (2004) Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. Drug Metab Dispos 32(11):1317–1324

    Article  CAS  PubMed  Google Scholar 

  • Magura EI, Kopanitsa MV, Gleitz J, Peters T, Krishtal OA (1997) Kava extract ingredients, (+)-methysticin and (±)-kavain inhibit voltage-operated Na+ channels in rat CA1 hippocampal neurons. Neuroscience 81(2):345–351

    Article  CAS  PubMed  Google Scholar 

  • Malsch U, Kieser M (2001) Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Psychopharmacology (Berl) 157(3):277–283

    Article  CAS  Google Scholar 

  • Martin HB, Stofer WD, Eichinger MR (2000) Kavain inhibits murine airway smooth muscle contraction. Planta Med 66(7):601–606

    Article  CAS  PubMed  Google Scholar 

  • Martin HB, McCallum M, Stofer WD, Eichinger MR (2002) Kavain attenuates vascular contractility through inhibition of calcium channels. Planta Med 68(9):784–789

    Article  CAS  PubMed  Google Scholar 

  • Mathews JD, Riley MD, Fejo L, Munoz E, Milns NR, Gardner ID, Powers JR, Ganygulpa E, Gununuwawuy BJ (1988) Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. Med J Aust 148(11):548–555

    CAS  PubMed  Google Scholar 

  • Mathews JM, Etheridge AS, Black SR (2002) Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 30(11):1153–1157

    Article  CAS  PubMed  Google Scholar 

  • Mathews JM, Etheridge AS, Valentine JL, Black SR, Coleman DP, Patel P, So J, Burka LT (2005) Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro. Drug Metab Dispos 33(10):1555–1563

    Article  CAS  PubMed  Google Scholar 

  • Matsuda H, Hirata N, Kawaguchi Y, Naruto S, Takata T, Oyama M, Iinuma M, Kubo M (2006) Melanogenesis stimulation in murine B16 melanoma cells by Kava (Piper methysticum) rhizome extract and kavalactones. Biol Pharm Bull 29(4):834–837

    Article  CAS  PubMed  Google Scholar 

  • Matthias A, Blanchfield JT, Penman KG, Bone KM, Toth I, Lehmann RP (2007) Permeability studies of kavalactones using a Caco-2 cell monolayer model. J Clin Pharm Ther 32(3):233–239

    Article  CAS  PubMed  Google Scholar 

  • McDonald D, Jowitt A (2000) Kava in the Pacific Islands: a contemporary drug of abuse? Drug Alcohol Rev 19(2):217–227

    Article  Google Scholar 

  • Meissner O, Häberlein H (2005) HPLC analysis of flavokavins and kavapyrones from Piper methysticum Forst. J Chromatogr B Analyt Technol Biomed Life Sci 826(1–2):46–49

    Article  CAS  PubMed  Google Scholar 

  • Meseguer E, Taboada R, Sánchez V, Mena MA, Campos V, García de Yébenes J (2002) Life-threatening parkinsonism induced by kava-kava. Mov Disord 17(1):195–196

    Article  PubMed  Google Scholar 

  • Meyer HJ (1962) Pharmakologie der wirksamen prinzipien des kawa-rhizoms (Piper methysticum Forst.). Arch Int Pharmacodyn Ther 138(3–4):505–536. (In German)

    CAS  PubMed  Google Scholar 

  • Meyer HJ (1965) Spasmolytische effekte von dihydromethysticin, einem wirkstoff aus Piper methysticum Forst. [Spasmolytic effect of dihydromethysticin, a constituent of Piper methysticum Forst]. Arch Int Pharmacodyn Ther 154:449–467. (In German)

    CAS  PubMed  Google Scholar 

  • Meyer HJ, May HU (1964) Lokalanaesthetische eigenschaften natürlicher kawa-pyrone. KlinWochenschr 42(8):407. (In German)

    Article  CAS  Google Scholar 

  • Meyer HJ, Meyer-Burg J (1964) Hemmung des elektrokrampfes durch die kawa-pyrone dihydromethysticin und dihydrokawain. Arch Int Pharmacodyn Ther 148:97–110. (In German)

    CAS  PubMed  Google Scholar 

  • Morse Z, Sharma VA (2005) A novel topical anaesthetic from Piper methysticum (kava) – kavacaine. Fiji Med J 24(1):8–9

    Google Scholar 

  • Mouritz AASM (1916) The path of the destroyer. A history of leprosy in the Hawaiian Islands and thirty years research into the means by which it has spread. Honolulu-Star Bull, Honolulu, pp 79–82

    Google Scholar 

  • Münte TF, Heinze HJ, Matzke M, Steitz J (1993) Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 27(1):46–53

    Article  PubMed  Google Scholar 

  • Musch E, Chrissafidou A, Malek M (2006) Acute hepatitis due to kava-kava and St John’s Wort: an immune-mediated mechanism? Dtsch Med Wochenschr 131(21):1214–1217. (In German)

    Article  CAS  PubMed  Google Scholar 

  • Narayanapillai SC, Balbo S, Leitzman P, Grill AE, Upadhyaya P, Shaik AA, Zhou B, O’Sullivan MG, Peterson LA, Lu J, Hecht SS, Xing C (2014a) Dihydromethysticin (DHM) from kava blocks tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis and differentially reduces DNA damage in A/J mice. Carcinogenesis 35(10):2365–2372

    Article  PubMed Central  PubMed  Google Scholar 

  • Narayanapillai SC, Leitzman P, O’Sullivan MG, Xing C (2014b) Flavokawains A and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice. Chem Res Toxicol 27(10):1871–1876

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • National Centre for Complementary and Alternative Medicine (NCAM) (2006) Kava. US Dept Health and Human Serives. http://nccam.nih.gov/sites/nccam.nih.gov/files/Herbs_At_A_Glance_Kava_06-15-2012_0.pdf

  • National Toxicology Program (NTP) (2012) Toxicology and carcinogenesis studies of kava kava extract (CAS No. 9000-38-8) in F344/N rats and B6C3F1 mice (Gavage Studies), Natl Toxicol Program Tech Rep Ser 571. US Department of Health and Human Services, Washington DC, pp 1–186

    Google Scholar 

  • Naumov P, Dragull K, Yoshioka M, Tang CS, Ng SW (2008) Structural characterization of genuine (−)-pipermethystine, (−)-epoxypipermethystine, (+)-dihydromethysticin and yangonin from the kava plant (Piper methysticum). Nat Prod Comm 3(8):1333–1336

    CAS  Google Scholar 

  • Nerurkar PV, Dragull K, Tang C-S (2004) In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to Kava lactones. Toxicol Sci 79:106–111

    Article  CAS  PubMed  Google Scholar 

  • Nolting E, Kopp A (1874) Sur la racine de kava. Moniteur Scientifique 14:920–923

    Google Scholar 

  • Norton SA, Ruze P (1994) Kava dermopathy. J Am Acad Dermatol 31(1):89–97

    Article  CAS  PubMed  Google Scholar 

  • Nowakowska E, Ostrowicz A, Chodera A (1998) Kava-kava preparations – alternative anxiolytics. Pol Merkur Lekarski 4(21):179-180a. (In Polish)

    Google Scholar 

  • O’Hara MJ, Kinnard WJ, Buckley JP (1965) Preliminary characterization of aqueous extracts of Piper methysticum (kava, kawa kawa). J Pharm Sc 54(7):1021–1025

    Article  Google Scholar 

  • Olsen LR, Grillo MP, Skonberg C (2011) Constituents in kava extracts potentially involved in hepatotoxicity: a review. Chem Res Toxicol 24(7):992–1002

    Article  CAS  PubMed  Google Scholar 

  • Onwueme IC (2000) Piper methysticum G. Forster. In: van der Vossen HAM, Wessel M (eds) Plant resources of South East Asia No 16. Stimulants. Backhuys Publishers, Leiden, pp 106–108

    Google Scholar 

  • Otoguro K, Iwatsuki M, Ishiyama A, Namatame M, Nishihara-Tsukashima A, Kiyohara H, Hashimoto T, Asakawa Y, Omura S, Yamada H (2012) In vitro antitrypanosomal activity of some phenolic compounds from propolis and lactones from Fijian Kawa (Piper methysticum). J Nat Med 66(3):558–561

    Article  CAS  PubMed  Google Scholar 

  • Parham HBR (1939) Fiji plants, their names and uses. J Polynes Soc 48:48–50

    Google Scholar 

  • Parham HBR (1941) Fji Plants, their names and uses Memoir No 16 Supplement. J Polynes Soc 50:137

    Google Scholar 

  • Parker JA, Kurien TT, Huppatz C (2014) Hepatitis A outbreak associated with kava drinking. Commun Dis Intell Q Rep 38(1):E26–E28

    PubMed  Google Scholar 

  • Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, Tyagi OD, Prasad AK, Wengel J, Olsen CE, Boll PM (1997) Phytochemistry of the genus Piper. Phytochemistry 64(4):597–673

    Article  Google Scholar 

  • Pittler MH, Ernst E (2003) Kava extract for treating anxiety. Cochrane Database Syst Rev 2003(1):CD003383

    Google Scholar 

  • Pollastri MP, Whitty A, Merrill JC, Tang X, Ashton TD, Amar S (2009) Identification and characterization of kava-derived compounds mediating TNF-alpha suppression. Chem Biol Drug Des 74(2):121–128

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ranjith H, Dharmaratne W, Nanayakkara NPD, Khan IA (2002) Kavalactones from Piper methysticum, and their 13C NMR spectroscopic analyses. Phytochemistry 59(4):429–433

    Article  Google Scholar 

  • Rasmussen AK, Scheline RR, Solheim E (1979) Metabolism of some kava pyrones in the rat. Xenobiotica 9(1):1–16

    Article  CAS  PubMed  Google Scholar 

  • Reichert RG (1997) Kav-kava: the anti-anxiety herb that relaxes and sharpens the mind. Keat Puiblishing Inc, New Canaan

    Google Scholar 

  • Rex A, Morgenstern E, Fink H (2002) Anxiolytic-like effects of kava-kava in the elevated plus maze test – a comparison with diazepam. Prog Neuropsychopharmacol Biol Psychiatry 26(5):855–860

    Article  CAS  PubMed  Google Scholar 

  • Robinson V, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW, Cosmetic Ingredient Review Expert Panel, Andersen FA (2009) Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract. Int J Toxicol 28(6 Suppl):175S–188S

    Article  CAS  PubMed  Google Scholar 

  • Rowe A, Ramzan I (2012) Are mould hepatotoxins responsible for kava hepatotoxicity? Phytother Res 26(11):1768–1770

    Article  CAS  PubMed  Google Scholar 

  • Rowe A, Zhang LY, Ramzan I (2011) Toxicokinetics of kava. Adv Pharmacol Sci 2011:326724

    PubMed Central  PubMed  Google Scholar 

  • Russell PN, Bakker D, Singh NN (1987) The effects of kava on alerting and speed of access of information from long-term memory. Bull Psychonomic Soc 25(4):236–237

    Article  Google Scholar 

  • Russmann S, Lauterburg BH, Helbling A (2001) Kava hepatotoxicity. Ann Int Med 135(1):68–69

    Article  CAS  PubMed  Google Scholar 

  • Russmann S, Barguil Y, Cabalion P, Kritsanida M, Duhet D, Lauterburg BH (2003) Hepatic injury due to traditional aqueous extracts of kava root in New Caledonia. Eur J Gastroenterol Hepatol 15(9):1033–1036

    Article  PubMed  Google Scholar 

  • Ruze P (1990) Kava induced dermopathy: a niacin deficiency? Lancet 335(8703):1442–1445

    Article  CAS  PubMed  Google Scholar 

  • Rychetnik L, Madronio CM (2011) The health and social effects of drinking water-based infusions of kava: a review of the evidence. Drug Alcohol Rev 30(1):74–83

    Article  PubMed  Google Scholar 

  • Sakai T, Eskander RN, Guo Y, Kim KJ, Mefford J, Hopkins J, Bhatia NN, Zi XL, Hoang BH (2012) Flavokawain B, a kava chalcone, induces apoptosis in synovial sarcoma cell lines. J Orthop Res 30(7):1045–1050

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Saletu B, Grünberger J, Linzmayer L, Anderer P (1989) EEG-brain mapping, psychometric and psychophysiological studies on central effects of kavain – a kava plant derivative. Hum Psychopharmacol Clin Exp 4:169–190

    Article  CAS  Google Scholar 

  • Sarris J, Kavanagh DJ, Adams J, Bone K, Byrne G (2009a) Kava Anxiety Depression Spectrum Study (KADSS): a mixed method RCT using an aqueous extract of Piper methysticum. Complement Ther Med 17(3):176–178

    Article  CAS  PubMed  Google Scholar 

  • Sarris J, Kavanagh DJ, Byrne G, Bone KM, Adams J, Deed G (2009b) The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology (Berl) 205(3):399–407

    Article  CAS  Google Scholar 

  • Sarris J, LaPorte E, Schweitzer I (2011) Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Aust N Z J Psychiatry 45(1):27–35

    Article  PubMed  Google Scholar 

  • Sarris J, Scholey A, Schweitzer I, Bousman C, Laporte E, Ng C, Murray G, Stough C (2012) The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study. Hum Psychopharmacol 27(3):262–269

    Article  CAS  PubMed  Google Scholar 

  • Sarris J, Laporte E, Scholey A, King R, Pipingas A, Schweitzer I, Stough C (2013a) Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study. Traffic Inj Prev 14(1):13–17

    Article  CAS  PubMed  Google Scholar 

  • Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I (2013b) Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol 33(5):643–648

    Article  PubMed  Google Scholar 

  • Sarris J, Stough C, Teschke R, Wahid ZT, Bousman CA, Murray G, Savage KM, Mouatt P, Ng C, Schweitzer I (2013c) Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects. Phytother Res 27(11):1723–1728

    Article  CAS  PubMed  Google Scholar 

  • Schelosky L, Raffauf C, Jendroska K, Poewe W (1995) Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry 58(5):639–640

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Scherer J (1998) Kava-kava extract in anxiety disorders: an outpatient observational study. Adv Ther 15(4):261–269

    CAS  PubMed  Google Scholar 

  • Schirrmacher K, Büsselberg D, Langosch JM, Walden J, Winter U, Bingmann D (1999) Effects of (+/−)-kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats. Eur Neuropsychopharmacol 9(1–2):171–176

    Article  CAS  PubMed  Google Scholar 

  • Schmidt N, Ferger B (2001) Neuroprotective effects of (+/−)-kavain in the MPTP mouse model of Parkinson’s disease. Synapse 40(1):47–54

    Article  CAS  PubMed  Google Scholar 

  • Schmitz D, Zhang CL, Chatterjee SS, Heinemann U (1995) Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices. Naunyn Schmiedebergs Arch Pharmacol 351(4):348–355

    Article  CAS  PubMed  Google Scholar 

  • Schultes RE, Hoffman A (1992) Plants of the gods: their sacred, healing and hallucinogenic powers. Healing Arts Press, Rochester

    Google Scholar 

  • Seitz U, Ameri A, Pelzer H, Gleitz J, Peters T (1997a) Relaxation of evoked contractile activity of isolated guinea-pig ileum by (+/−)-kavain. Planta Med 63(4):303–306

    Article  CAS  PubMed  Google Scholar 

  • Seitz U, Schule A, Gleitz J (1997b) [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Med 63(6):548–549

    Article  CAS  PubMed  Google Scholar 

  • Shaik AA, Hermanson DL, Xing C (2009) Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava’s chemopreventive activity. Bioorg Med Chem Lett 19(19):5732–5736

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shao Y, He K, Zheng B, Zheng QY (1998) Reversed-phase high-performance liquid chromatographic method for quantitative analysis of the six major kavalactones in Piper methysticum. J Chromatogr A 825(1):1–8

    Article  CAS  Google Scholar 

  • Shimoda LM, Park C, Stokes AJ, Gomes HH, Turner H (2012) Pacific island’ Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells. Phytother Res 26(12):1934–1941

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Shinomiya K, Inoue T, Utsu Y, Tokunaga S, Masuoka T, Ohmori A, Kamei C (2005) Effects of kava-kava extract on the sleep-wake cycle in sleep-disturbed rats. Psychopharmacology (Berl) 180(3):564–569

    Article  CAS  Google Scholar 

  • Shulgin AT (1973) The narcotic pepper – the chemistry and pharmacology of Piper methysticum and related species. Bull Narc 25:59–74

    CAS  Google Scholar 

  • Siegel RK (1976) Herbal intoxication. Psychoactive effects from herbal cigarettes, tea, and capsules. J Am M Assoc 236(5):473–476

    Article  CAS  Google Scholar 

  • Singh YN (1983) Effects of kava on neuromuscular transmission and muscle contractility. J Ethnopharmacol 7(3):267–276

    Article  CAS  PubMed  Google Scholar 

  • Singh YN (1992) Kava: an overview. J Ethnopharmacol 37:13–45

    Article  CAS  PubMed  Google Scholar 

  • Singh YN (2004) Kava: from ethnology to pharmacology. CRC Press, London/New York. 167pp

    Google Scholar 

  • Singh YN, Blumenthal M (1997) Kava, an overview. HerbalGram 39:34–56

    Google Scholar 

  • Singh YN, Devkota AK (2003) Aqueous kava extracts do not affect liver function tests in rats. Planta Med 69(6):496–499

    Article  CAS  PubMed  Google Scholar 

  • Singh YN, Singh NN (2002) Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 16(11):731–743

    Article  PubMed  Google Scholar 

  • Smith RM (1979) Pipermethystine, a novel pyridine alkaloid. Tetrahedron 35:437–439

    Article  CAS  Google Scholar 

  • Smith RM (1983) Kava lactones in Piper methysticum from Fiji. Phytochemistry 22(4):1055–1056

    Article  CAS  Google Scholar 

  • Smith KK, Dharmaratne HR, Feltenstein MW, Broom SL, Roach JT, Nanayakkara NP, Khan IA, Sufka KJ (2001) Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology (Berl) 155(1):86–90

    Article  CAS  Google Scholar 

  • Sorrentino L, Capasso A, Schmidt M (2006) Safety of ethanolic kava extract: results of a study of chronic toxicity in rats. Phytomedicine 13(8):542–549

    Article  CAS  PubMed  Google Scholar 

  • Sotheeswaran (1987) Kava and the Australian aborigine. Chemistry in Australia. pp 377–378

    Google Scholar 

  • Sparreboom A, Cox MC, Acharya MR, Figg WD (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22(12):2489–2503

    Article  CAS  PubMed  Google Scholar 

  • Spillane PK, Fisher DA, Currie BJ (1997) Neurological manifestations of kava intoxication. Med J Australia 167(3):172–173

    CAS  PubMed  Google Scholar 

  • Steiner GG (2000) The correlation between cancer incidence and kava consumption. Hawaii Med J 59(11):420–422

    CAS  PubMed  Google Scholar 

  • Steinmetz EF (1960) Piper methysticum, kava, kawa, yaqona, famous drug plant of the South Sea Islands. E.F. Steinmetz, Amerstemdam. 46 pp

    Google Scholar 

  • Sterly J (1970) Heilpflanzen der einwohner Melanesians. Beiträge zur ethnobotanik des südwestlichen Pazifik. Hamburger Reihe zur Kultur – und Sprachwissenschaft Bd 6. Hamburg, München. (In German)

    Google Scholar 

  • Stickel F, Baumüller HM, Seitz K, Vasilakis D, Seitz G, Seitz HK, Schuppan D (2003) Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepatol 39(1):62–67

    Article  CAS  PubMed  Google Scholar 

  • Strahl S, Ehret V, Dahm HH, Maier KP (1998) Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr 123(47):1410–1414

    Article  CAS  PubMed  Google Scholar 

  • Sullivan J, Romm J, Reilly M (2009) A brief report of student research: mechanism of analgesic effect and efficacy and anesthesia interactions of kava in the male Sprague-Dawley rat. Dimens Crit Care Nurs 28(3):138–140

    Article  PubMed  Google Scholar 

  • Süss R, Lehmann P (1996) Hämatogenes kontaktekzem durch pflanzliche medikamente am beispiel des kavawurzel-extraktes. (Hematogenous contact eczema cause by phytogenic drugs exemplified by kava root extract). Hautarzt 47(6):459–461. (In German)

    Article  PubMed  Google Scholar 

  • Tabudravu JN, Jaspars M (2005) Anticancer activities of constituents of kava (Piper methysticum). South Pac J Nat Sci 23:26–29

    Article  Google Scholar 

  • Tang YX, Simoneau AR, Xie J, Shahandeh B, Zi XL (2008) Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev Res (Phila Pa) 1(6):439–451

    Article  CAS  Google Scholar 

  • Tang YX, Li XS, Liu ZB, Simoneau AR, Xie J, Zi XL (2010) Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int J Cancer 127(8):1758–1768

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Tarbah F, Barguil Y, Müller C, Rickett A, Weinmann W, Nour M, Kintz P, Daldrup T (2013) Chromatographic hair analysis for natural kavalactones and their metabolites. A preliminary study. Ann Toxicol Anal 25(3):109–119

    Article  CAS  Google Scholar 

  • Terazawa R, Akimoto N, Kato T, Itoh T, Fujita Y, Hamada N, Deguchi T, Iinuma M, Noda M, Nozawa Y, Ito M (2013) A kavalactone derivative inhibits lipopolysaccharide-stimulated iNOS induction and NO production through activation of Nrf2 signaling in BV2 microglial cells. Pharmacol Res 71:34–43

    Article  CAS  PubMed  Google Scholar 

  • Teschke R (2003) Kava, kavapyrones and toxic liver injury. Z Gastroenterol 41(5):395–404. (In German)

    Article  CAS  PubMed  Google Scholar 

  • Teschke R (2010) Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 30(9):1270–1279

    Article  PubMed  Google Scholar 

  • Teschke R (2011) Kava and the risk of liver toxicity: past, current, and future. AHPA special report. The American Herbal Products Association. http://www.ahpa.org/portals/0/pdfs/11_0303_March2011_AHPA_Report_Kava_Special_Report.pdf

  • Teschke R, Lebot V (2011) Proposal for a kava quality standardization code. Food Chem Toxicol 49(10):2503–2516

    Article  CAS  PubMed  Google Scholar 

  • Teschke R, Schwarzenboeck A, Hennermann KH (2008) Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 20(12):1182–1193

    Article  PubMed  Google Scholar 

  • Teschke R, Genthner A, Wolff A (2009) Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol 123(3):378–384

    Article  CAS  PubMed  Google Scholar 

  • Teschke R, Fuchs J, Bahre R, Genthner A, Wolff A (2010) Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. J Clin Pharm Ther 35(5):545–563

    Article  CAS  PubMed  Google Scholar 

  • Teschke R, Qiu SX, Lebot V (2011a) Herbal hepatotoxicity by kava: update on pipermethystine, flavokavain B, and mould hepatotoxins as primarily assumed culprits. Dig Liver Dis 43(9):676–681

    Article  CAS  PubMed  Google Scholar 

  • Teschke R, Qiu SX, Xuan TD, Lebot V (2011b) Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. Phytother Res 25(9):1263–1274

    CAS  PubMed  Google Scholar 

  • Teschke R, Sarris J, Glass X, Schulze J (2011c) Kava, the anxiolytic herb: back to basics to prevent liver injury? Br J Clin Pharmacol 71(3):445–448

    Article  PubMed Central  PubMed  Google Scholar 

  • Teschke R, Sarris J, Lebot V (2011d) Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine 18(2–3):96–103

    Article  CAS  PubMed  Google Scholar 

  • Teschke R, Sarris J, Schweitzer I (2012) Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. Br J Clin Pharmacol 73(2):170–174

    Article  PubMed Central  PubMed  Google Scholar 

  • Teschke R, Sarris J, Lebot V (2013) Contaminant hepatotoxins as culprits for kava hepatotoxicity – fact or fiction? Phytother Res 27(3):472–474

    Article  PubMed  Google Scholar 

  • Thompson R, Ruch W, Hasenöhrl RU (2004) Enhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava). Hum Psychopharmacol 19(4):243–250

    Article  CAS  PubMed  Google Scholar 

  • Thomson B (1908) The Fijian: a study of the decay of custom. W. Heinemann, London, 396 pp

    Google Scholar 

  • Tinsley JA (1999) The hazards of psychotropic herbs. Minn Med 82(5):29–31

    CAS  PubMed  Google Scholar 

  • Titcomb M (1948) Kava in Hawaii. J Polynes Soc. 57(2):105-171l.

    Google Scholar 

  • Toohey TP, Lu BY, Wada C (2013) Toxic effects of psychotropics related to possible p450 enzyme inhibition by kava: report of 2 cases. Prim Care Companion CNS Disord 15(5). pii: PCC.13br01539

    Google Scholar 

  • Triolet J, Shaik AA, Gallaher DD, O’Sullivan MG, Xing C (2012) Reduction in colon cancer risk by consumption of kava or kava fractions in carcinogen-treated rats. Nutr Cancer 64(6):838–846

    Article  PubMed  Google Scholar 

  • Tyron DT (1976) New Hebrides language: an internal classification, Pacific linguistics, series C, no 50. Department of Linguistics, Research School of Pacific Studies, Australian National University, Canberra. 545 pp

    Google Scholar 

  • Uebelhack R, Franke L, Schewe HJ (1998) Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry 31(5):187–192

    Article  CAS  PubMed  Google Scholar 

  • Unger M, Holzgrabe U, Jacobsen W, Cummins C, Benet LZ (2002) Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava). Planta Med 68(12):1055–1058

    Article  CAS  PubMed  Google Scholar 

  • van Veen AG (1939) Isolation and constitution of the narcotic substance from kawa-kawa, (Piper methysticum). Recl Trav Chim Pays-Bas 58(6):521–527

    Article  Google Scholar 

  • Vienne B (1981) Les usages médicinaux de quelques plantes communes de la flore des îles Banks, Vanuatu. In: Médecines et santé. Cahier ORSTOM Ser Sci Hum 18(4):569–589. (In French)

    Google Scholar 

  • Vignier N, Lert F, Salomon C, Hamelin C (2011) Kava drinking associated with suicidal behaviour among young Kanaks using kava in New Caledonia. Aust N Z J Public Health 35(5):427–433

    Article  PubMed  Google Scholar 

  • Volz HP, Kieser M (1997) Kava-kava extract WS 1490 versus placebo in anxiety disorders – a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 30(1):1–5

    Article  CAS  PubMed  Google Scholar 

  • Walden J, von Wegerer J, Winter U, Berger M (1997a) Actions of kavain and dihydromethysticin on ipsapirone-induced field potential changes in the hippocampus. Hum Psychopharmacol 12(3):265–270

    Article  CAS  Google Scholar 

  • Walden J, von Wegerer J, Winter U, Berger M, Grunze H (1997b) Effects of kawain and dihydromethysticin on field potential changes in the hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 21(4):697–706

    Article  CAS  PubMed  Google Scholar 

  • Warmka JK, Solberg EL, Zeliadt NA, Srinivasan B, Charlson AT, Xing C, Wattenberg EV (2012) Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog. Biochem Biophys Res Commun 424(3):488–492

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Warnecke G (1991) Psychosomatische dysfunktionen im weiblichen klimakterium. Klinische wirksamkeit und verträglichkeit von kawa-extrakt WS 1490. Fortschr Med 109:119–122

    CAS  PubMed  Google Scholar 

  • Warnecke G, Pfaender H, Gerster G, Gracza E (1990) Wirksamkeit von kawa-kawa-extrakt beim klimakterischen syndrom. Z Phytother 11:81–86

    Google Scholar 

  • Watkins LL, Connor KM, Davidson JR (2001) Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings. J Psychopharmacol 15(4):283–286

    Article  CAS  PubMed  Google Scholar 

  • Weiss J, Sauer A, Frank A, Unger M (2005) Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab Dispos 33(11):1580–1583

    Article  CAS  PubMed  Google Scholar 

  • Whittaker P, Clarke JJ, San RH, Betz JM, Seifried HE, de Jager LS, Dunkel VC (2008) Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Food Chem Toxicol 46(1):168–174

    Article  CAS  PubMed  Google Scholar 

  • Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS (2003) Kava lactones and the kava-kava controversy. Phytochemistry 64(3):673–679

    Article  CAS  PubMed  Google Scholar 

  • Winzheimer E (1908) Beiträge zur kenntnis der kawawurzel. Arch Pharm 246:338–365. (In German)

    Article  Google Scholar 

  • Woelk H, Kapoula S, Lehrl S, Schroter K, Weinholz P (1993) Treatment of patients suffering from anxiety – double-blind study: Kava special extract versus benzodiazepines. Z Allegemeinmed 69:271–277

    Google Scholar 

  • World Health Organization (WHO) (2007) Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services, Geneva

    Google Scholar 

  • Wu D, Nair MG, DeWitt DL (2002a) Novel compounds from Piper methysticum Forst (Kava Kava) roots and their effect on cyclooxygenase enzyme. J Agric Food Chem 50(4):701–705

    Article  CAS  PubMed  Google Scholar 

  • Wu D, Yu L, Nair MG, De Witt DL, Ramsewak RS (2002b) Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 9(1):41–47

    Article  CAS  PubMed  Google Scholar 

  • Xia Q, Chiang HM, Zhou YT, Yin JJ, Liu F, Wang C, Guo L, Fu PP (2012) Phototoxicity of kava – formation of reactive oxygen species leading to lipid peroxidation and DNA damage. Am J Chin Med 40(6):1271–1288

    Article  CAS  PubMed  Google Scholar 

  • Xuan TD, Yuichi O, Junko C, Tsuzuki E, Hiroyuki T, Mitsuhiro M, Khanh TD, Hong NH (2003) Kava root (Piper methysticum L.) as a potential natural herbicide and fungicide. Crop Protect 22(6):873–881

    Article  Google Scholar 

  • Xuan TD, Elzaawely AA, Fukuta M, Tawata S (2006) Herbicidal and fungicidal activities of lactones in kava (Piper methysticum). J Agric Food Chem 54(3):720–725

    Google Scholar 

  • Xuan TD, Fukuta M, Wei AC, Elzaawely AA, Khanh TD, Tawata S (2008) Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots. J Nat Med 62(2):188–194

    Article  CAS  PubMed  Google Scholar 

  • Yamazaki Y, Hashida H, Arita A, Hamaguchi K, Shimura F (2008) High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats. Food Chem Toxicol 46(12):3732–3738

    Article  CAS  PubMed  Google Scholar 

  • Yang X, Salminen WF (2011) Kava extract, an herbal alternative for anxiety relief, potentiates acetaminophen-induced cytotoxicity in rat hepatic cells. Phytomedicine 18(7):592–600

    Article  CAS  PubMed  Google Scholar 

  • Young RL, Hylin JW, Plucknett DL, Kawano Y, Nakayama RT (1966) Analysis for kawa pyrones in extracts of Piper methysticum. Phytochemistry 5(4):795–798

    Google Scholar 

  • Zepernick B (1972) Arneipflanzen der Polynesier. Verlag Von dietrcih Remier, Berlin. 307 pp

    Google Scholar 

  • Zhang LY, Rowe A, Ramzan I (2011) Does inflammation play a role in kava hepatotoxicity? Phytother Res 25(4):629–630

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Rowe A, Braet F, Ramzan I (2013) Macrophage depletion ameliorates kavalactone damage in the isolated perfused rat liver. J Toxicol Sci 37(2):447–453

    Article  Google Scholar 

  • Zhao X, Chao YL, Wan QB, Chen XM, Su P, Sun J, Tang YX (2011) Flavokawain B induces apoptosis of human oral adenoid cystic cancer ACC-2 cells via up-regulation of Bim and down-regulation of Bcl-2 expression. Can J Physiol Pharmacol 89(12):875–883

    Article  CAS  PubMed  Google Scholar 

  • Zhou P, Gross S, Liu JH, Yu BY, Feng LL, Nolta J, Sharma V, Piwnica-Worms D, Qiu SX (2010) Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways. FASEB J 24(12):4722–4732

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zi XL, Simoneau AR (2005) Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res 65(8):3479–3486

    CAS  PubMed  Google Scholar 

  • Zou L, Harkey MR, Henderson GL, Dike LE (2004a) Kava does not display metabolic toxicity in a homogeneous cellular assay. Planta Med 70(4):289–292

    Article  CAS  PubMed  Google Scholar 

  • Zou L, Henderson GL, Harkey MR, Sakai Y, Li A (2004b) Effects of kava (Kava-kava, ‘Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes. Phytomedicine 11(4):285–294

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Canberra, Australia

    T. K. Lim

Authors
  1. T. K. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lim, T.K. (2016). Piper methysticum . In: Edible Medicinal and Non-Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-319-26062-4_15

Download citation

Publish with us

Policies and ethics

Search

Navigation